Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalization of Maintenance Immunosuppression Based on TTV Viral Load in Renal Transplantation
NCT06829719Recruiting
- Sponsor
- Hospices Civils de Lyon
- Start
- Apr 2025
- Primary completion
- May 2028
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Time to first complication of inadequate immunosuppression. Started Apr 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06829719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06829719.